37th Annual Advances in Heart Disease

 

37th Annual Advances in Heart Disease
K

P2Y12 Inhibitors of Platelet Function During and Following PCI: What Are the Differences Between Oral P2Y12 Inhibitors and Which One to Choose? How Long to Use DAPT After PCI?

By 37th Annual Advances in Heart Disease FEATURING Krishan Soni, Lucas Zier
By 37th Annual Advances in Heart Disease FEATURING Krishan Soni, Lucas Zier
0 views
February 19, 2021
Comments 1
Login to view comments. Click here to Login
Day 3
33:49
37th Annual Advances in Heart Disease

Heart Failure and Iron Supplementation: Can Erythropoietin, Iron Suc…

Feat. J. Kennedy, L. Zier
40:33
37th Annual Advances in Heart Disease

P2Y12 Inhibitors of Platelet Function During and Following PCI: What…

Feat. K. Soni, L. Zier
25:12
37th Annual Advances in Heart Disease

Management of Multivessel CAD and STEMI: Treating Culprit Lesion Onl…

Feat. K. Soni, L. Zier
32:24
37th Annual Advances in Heart Disease

Clinical Utility and Implementation of High Sensitivity Cardiac Trop…

Feat. R. Vigen
16:16
37th Annual Advances in Heart Disease

Management of Left Main Coronary Artery Disease: Should You Perform …

Feat. L. Zier
18:18
37th Annual Advances in Heart Disease

Management of Left Main Coronary Artery Disease: Should You Perform …

Feat. A. Hill
08:31
37th Annual Advances in Heart Disease

Debate on the Management of Left Main Coronary Artery Disease: PCI v…

Feat. L. Zier, A. Hill, P. Ganz
34:34
37th Annual Advances in Heart Disease

Transcatheter Valve-in-Valve Implantation in Failed Aortic Bioprosth…

Feat. J. Zimmet, L. Zier
38:28
37th Annual Advances in Heart Disease

Left Atrial Appendage Closure: What Are the Advantages and Disadvant…

Feat. T. Dewland, L. Zier
30:03
37th Annual Advances in Heart Disease

Effect of Bariatric Surgery on Cardiovascular Outcomes: Can It Abrog…

Feat. M. Crawford